176 related articles for article (PubMed ID: 24258200)
1. Epidermal overexpression of transgenic ΔNp63 promotes type 2 immune and myeloid inflammatory responses and hyperplasia via NF-κB activation.
Du J; Romano RA; Si H; Mattox A; Bian Y; Yang X; Sinha S; Van Waes C; Chen Z
J Pathol; 2014 Feb; 232(3):356-68. PubMed ID: 24258200
[TBL] [Abstract][Full Text] [Related]
2. ΔNp63 versatilely regulates a Broad NF-κB gene program and promotes squamous epithelial proliferation, migration, and inflammation.
Yang X; Lu H; Yan B; Romano RA; Bian Y; Friedman J; Duggal P; Allen C; Chuang R; Ehsanian R; Si H; Sinha S; Van Waes C; Chen Z
Cancer Res; 2011 May; 71(10):3688-700. PubMed ID: 21576089
[TBL] [Abstract][Full Text] [Related]
3. TNF-α modulates genome-wide redistribution of ΔNp63α/TAp73 and NF-κB cREL interactive binding on TP53 and AP-1 motifs to promote an oncogenic gene program in squamous cancer.
Si H; Lu H; Yang X; Mattox A; Jang M; Bian Y; Sano E; Viadiu H; Yan B; Yau C; Ng S; Lee SK; Romano RA; Davis S; Walker RL; Xiao W; Sun H; Wei L; Sinha S; Benz CC; Stuart JM; Meltzer PS; Van Waes C; Chen Z
Oncogene; 2016 Nov; 35(44):5781-5794. PubMed ID: 27132513
[TBL] [Abstract][Full Text] [Related]
4. Dysregulation of junctional adhesion molecule-A via p63/GATA-3 in head and neck squamous cell carcinoma.
Kakuki T; Kurose M; Takano K; Kondoh A; Obata K; Nomura K; Miyata R; Kaneko Y; Konno T; Takahashi S; Hatakeyama T; Kohno T; Himi T; Kojima T
Oncotarget; 2016 Jun; 7(23):33887-900. PubMed ID: 27036044
[TBL] [Abstract][Full Text] [Related]
5. ΔNp63 regulates IL-33 and IL-31 signaling in atopic dermatitis.
Rizzo JM; Oyelakin A; Min S; Smalley K; Bard J; Luo W; Nyquist J; Guttman-Yassky E; Yoshida T; De Benedetto A; Beck LA; Sinha S; Romano RA
Cell Death Differ; 2016 Jun; 23(6):1073-85. PubMed ID: 26768665
[TBL] [Abstract][Full Text] [Related]
6. Role of activated nuclear factor-kappaB in the pathogenesis and therapy of squamous cell carcinoma of the head and neck.
Allen CT; Ricker JL; Chen Z; Van Waes C
Head Neck; 2007 Oct; 29(10):959-71. PubMed ID: 17405170
[TBL] [Abstract][Full Text] [Related]
7. DeltaNp63 isoforms differentially regulate gene expression in squamous cell carcinoma: identification of Cox-2 as a novel p63 target.
Boldrup L; Coates PJ; Gu X; Nylander K
J Pathol; 2009 Aug; 218(4):428-36. PubMed ID: 19391123
[TBL] [Abstract][Full Text] [Related]
8. NF-κB and the link between inflammation and cancer.
DiDonato JA; Mercurio F; Karin M
Immunol Rev; 2012 Mar; 246(1):379-400. PubMed ID: 22435567
[TBL] [Abstract][Full Text] [Related]
9. Bortezomib-induced apoptosis with limited clinical response is accompanied by inhibition of canonical but not alternative nuclear factor-{kappa}B subunits in head and neck cancer.
Allen C; Saigal K; Nottingham L; Arun P; Chen Z; Van Waes C
Clin Cancer Res; 2008 Jul; 14(13):4175-85. PubMed ID: 18593997
[TBL] [Abstract][Full Text] [Related]
10. Aqueous extract of Vitex trifolia L. (Labiatae) inhibits LPS-dependent regulation of inflammatory mediators in RAW 264.7 macrophages through inhibition of Nuclear Factor kappa B translocation and expression.
Matsui M; Adib-Conquy M; Coste A; Kumar-Roiné S; Pipy B; Laurent D; Pauillac S
J Ethnopharmacol; 2012 Aug; 143(1):24-32. PubMed ID: 22732725
[TBL] [Abstract][Full Text] [Related]
11. Neutrophil-dominant psoriasis-like skin inflammation induced by epidermal-specific expression of Raf in mice.
Tarutani M; Imai Y; Yasuda K; Tsutsui H; Nakanishi K; Yamanishi K
J Dermatol Sci; 2010 Apr; 58(1):28-35. PubMed ID: 20188517
[TBL] [Abstract][Full Text] [Related]
12. Squamous cell carcinomas and increased apoptosis in skin with inhibited Rel/nuclear factor-kappaB signaling.
van Hogerlinden M; Rozell BL; Ahrlund-Richter L; Toftgård R
Cancer Res; 1999 Jul; 59(14):3299-303. PubMed ID: 10416581
[TBL] [Abstract][Full Text] [Related]
13. Nuclear factor-kappaB is an important modulator of the altered gene expression profile and malignant phenotype in squamous cell carcinoma.
Loercher A; Lee TL; Ricker JL; Howard A; Geoghegen J; Chen Z; Sunwoo JB; Sitcheran R; Chuang EY; Mitchell JB; Baldwin AS; Van Waes C
Cancer Res; 2004 Sep; 64(18):6511-23. PubMed ID: 15374962
[TBL] [Abstract][Full Text] [Related]
14. Tumor necrosis factor receptor 1-mediated signaling is required for skin cancer development induced by NF-kappaB inhibition.
Lind MH; Rozell B; Wallin RP; van Hogerlinden M; Ljunggren HG; Toftgård R; Sur I
Proc Natl Acad Sci U S A; 2004 Apr; 101(14):4972-7. PubMed ID: 15044707
[TBL] [Abstract][Full Text] [Related]
15. Inactivation of FIP200 leads to inflammatory skin disorder, but not tumorigenesis, in conditional knock-out mouse models.
Wei H; Gan B; Wu X; Guan JL
J Biol Chem; 2009 Feb; 284(9):6004-13. PubMed ID: 19106106
[TBL] [Abstract][Full Text] [Related]
16. NF-κB-induced microRNA-31 promotes epidermal hyperplasia by repressing protein phosphatase 6 in psoriasis.
Yan S; Xu Z; Lou F; Zhang L; Ke F; Bai J; Liu Z; Liu J; Wang H; Zhu H; Sun Y; Cai W; Gao Y; Su B; Li Q; Yang X; Yu J; Lai Y; Yu XZ; Zheng Y; Shen N; Chin YE; Wang H
Nat Commun; 2015 Jul; 6():7652. PubMed ID: 26138368
[TBL] [Abstract][Full Text] [Related]
17. Blockade of NF-kappaB improves cardiac function and survival without affecting inflammation in TNF-alpha-induced cardiomyopathy.
Kawamura N; Kubota T; Kawano S; Monden Y; Feldman AM; Tsutsui H; Takeshita A; Sunagawa K
Cardiovasc Res; 2005 Jun; 66(3):520-9. PubMed ID: 15914117
[TBL] [Abstract][Full Text] [Related]
18. Avarol inhibits TNF-alpha generation and NF-kappaB activation in human cells and in animal models.
Amigó M; Payá M; Braza-Boïls A; De Rosa S; Terencio MC
Life Sci; 2008 Jan; 82(5-6):256-64. PubMed ID: 18177902
[TBL] [Abstract][Full Text] [Related]
19. Expression of deltaNp63 in squamous cell carcinoma of the esophagus.
Morita M; Uramoto H; Nakata S; Ono K; Sugaya M; Yoshimatsu T; Oyama T; Hanagiri T; Sugio K; Yasumoto K
Anticancer Res; 2005; 25(5):3533-9. PubMed ID: 16101176
[TBL] [Abstract][Full Text] [Related]
20. Expression profiles of genes involved in the mouse nuclear factor-kappa B signal transduction pathway are modulated by mangiferin.
Leiro J; Arranz JA; Yáñez M; Ubeira FM; Sanmartín ML; Orallo F
Int Immunopharmacol; 2004 Jun; 4(6):763-78. PubMed ID: 15135318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
